Bacterial biosynthesis and maturation of the didemnin anti-cancer agents.

The anti-neoplastic agent didemnin B from the Caribbean tunicate Trididemnum solidum was the first marine drug to be clinically tested in humans. Because of its limited supply and its complex cyclic depsipeptide structure, considerable challenges were encountered during didemnin B's development that continue to limit aplidine (dehydrodidemnin B), which is currently being evaluated in numerous clinical trials. Herein we show that the didemnins are bacterial products produced by the marine α-proteobacteria Tistrella mobilis and Tistrella bauzanensis via a unique post-assembly line maturation process. Complete genome sequence analysis of the 6,513,401 bp T. mobilis strain KA081020-065 with its five circular replicons revealed the putative didemnin biosynthetic gene cluster (did) on the 1,126,962 bp megaplasmid pTM3. The did locus encodes a 13-module hybrid non-ribosomal peptide synthetase-polyketide synthase enzyme complex organized in a collinear arrangement for the synthesis of the fatty acylglutamine ester derivatives didemnins X and Y rather than didemnin B as first anticipated. Imaging mass spectrometry of T. mobilis bacterial colonies captured the time-dependent extracellular conversion of the didemnin X and Y precursors to didemnin B, in support of an unusual post-synthetase activation mechanism. Significantly, the discovery of the didemnin biosynthetic gene cluster may provide a long-term solution to the supply problem that presently hinders this group of marine natural products and pave the way for the genetic engineering of new didemnin congeners.

[1]  S. Eddy,et al.  tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence. , 1997, Nucleic acids research.

[2]  A sea of biosynthesis: marine natural products meet the molecular age. , 2011, Natural product reports.

[3]  Richard E. Moore,et al.  Sequence analysis and biochemical characterization of the nostopeptolide A biosynthetic gene cluster from Nostoc sp. GSV224. , 2003, Gene.

[4]  T. Molinski,et al.  Drug development from marine natural products , 2009, Nature Reviews Drug Discovery.

[5]  Fernando Albericio,et al.  Total Synthesis of Dehydrodidemnin B. Use of Uronium and Phosphonium Salt Coupling Reagents in Peptide Synthesis in Solution. , 1997, The Journal of organic chemistry.

[6]  Kai Blin,et al.  antiSMASH: rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequences , 2011, Nucleic Acids Res..

[7]  Mark Hildebrand,et al.  Identification of the putative bryostatin polyketide synthase gene cluster from "Candidatus Endobugula sertula", the uncultivated microbial symbiont of the marine bryozoan Bugula neritina. , 2007, Journal of natural products.

[8]  Feng-Biao Guo,et al.  ZCURVE: a new system for recognizing protein-coding genes in bacterial and archaeal genomes. , 2003, Nucleic acids research.

[9]  W. Gerwick,et al.  Isolation of swinholide A and related glycosylated derivatives from two field collections of marine cyanobacteria. , 2005, Organic letters.

[10]  J. Ravel,et al.  A global assembly line for cyanobactins. , 2008, Nature chemical biology.

[11]  A. Forman,et al.  Phase I/II clinical trial of didemnin B in non-small-cell lung cancer: neuromuscular toxicity is dose-limiting , 2004, Cancer Chemotherapy and Pharmacology.

[12]  Tilmann Weber,et al.  Specificity prediction of adenylation domains in nonribosomal peptide synthetases (NRPS) using transductive support vector machines (TSVMs) , 2005, Nucleic acids research.

[13]  Roger G. Linington,et al.  Highlights of marine invertebrate-derived biosynthetic products: their biomedical potential and possible production by microbial associants. , 2011, Bioorganic & medicinal chemistry.

[14]  Tistrella mobilis gen nov, sp nov, a novel polyhydroxyalkanoate-producing bacterium belonging to alpha-Proteobacteria. , 2002, The Journal of general and applied microbiology.

[15]  Tilmann Weber,et al.  Phylogenetic analysis of condensation domains in NRPS sheds light on their functional evolution , 2007, BMC Evolutionary Biology.

[16]  B. Banaigs,et al.  [Hysp2] and [Hap2]Didemnin B, two new [Hip2]-modified didemnin B from the tunicate Trididemnum cyanophorum , 1999 .

[17]  Judith N. Currano,et al.  Didemnins, tamandarins and related natural products. , 2012, Natural product reports.

[18]  Hye Kyong Kweon,et al.  Meta-omic characterization of the marine invertebrate microbial consortium that produces the chemotherapeutic natural product ET-743. , 2011, ACS chemical biology.

[19]  S. Tabata,et al.  Complete Genomic Structure of the Cultivated Rice Endophyte Azospirillum sp. B510 , 2010, DNA research : an international journal for rapid publication of reports on genes and genomes.

[20]  W. Gerwick,et al.  Cloning and biochemical characterization of the hectochlorin biosynthetic gene cluster from the marine cyanobacterium Lyngbya majuscula. , 2007, Journal of natural products.

[21]  Michael Y. Galperin,et al.  The COG database: a tool for genome-scale analysis of protein functions and evolution , 2000, Nucleic Acids Res..

[22]  M Zatyka,et al.  Control of genes for conjugative transfer of plasmids and other mobile elements. , 1998, FEMS microbiology reviews.

[23]  M. Joullié,et al.  Structure--activity relationships of side-chain modified didemnins. , 2001, Bioorganic & medicinal chemistry letters.

[24]  Daniela Barlocco,et al.  Privileged Structures as Leads in Medicinal Chemistry , 2006 .

[25]  Jacques Ravel,et al.  Natural combinatorial peptide libraries in cyanobacterial symbionts of marine ascidians , 2006, Nature chemical biology.

[26]  D. Faulkner,et al.  Highlights of marine natural products chemistry (1972-1999). , 2000, Natural product reports.

[27]  Bradley S Moore,et al.  Lessons from the past and charting the future of marine natural products drug discovery and chemical biology. , 2012, Chemistry & biology.

[28]  Narmada Thanki,et al.  CDD: a conserved domain database for interactive domain family analysis , 2006, Nucleic Acids Res..

[29]  Yi-Qiang Cheng.  Deciphering the Biosynthetic Codes for the Potent Anti‐SARS‐CoV Cyclodepsipeptide Valinomycin in Streptomyces tsusimaensis ATCC 15141 , 2006, Chembiochem : a European journal of chemical biology.

[30]  Pieter C. Dorrestein,et al.  A mass spectrometry-guided genome mining approach for natural product peptidogenomics , 2011, Nature chemical biology.

[31]  James R. Knight,et al.  Genome sequencing in microfabricated high-density picolitre reactors , 2005, Nature.

[32]  M. Schatz,et al.  Complex microbiome underlying secondary and primary metabolism in the tunicate-Prochloron symbiosis , 2011, Proceedings of the National Academy of Sciences.

[33]  Connecting chemotypes and phenotypes of cultured marine microbial assemblages by imaging mass spectrometry. , 2011, Angewandte Chemie.

[34]  C. Galmarini,et al.  The mechanism of action of plitidepsin. , 2009, Current opinion in investigational drugs.

[35]  E. Crawford,et al.  Phase II evaluation of didemnin B in hormonally refractory metastatic prostate cancer , 1995, Investigational New Drugs.

[36]  Matthias Platzer,et al.  Antitumor polyketide biosynthesis by an uncultivated bacterial symbiont of the marine sponge Theonella swinhoei. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Salzberg,et al.  Improved microbial gene identification with GLIMMER. , 1999, Nucleic acids research.

[38]  R. G. Hughes,et al.  Didemnins: antiviral and antitumor depsipeptides from a caribbean tunicate. , 1981, Science.

[39]  Yi-Qiang Cheng,et al.  Reconstitution of the FK228 Biosynthetic Pathway Reveals Cross Talk between Modular Polyketide Synthases and Fatty Acid Synthase , 2010, Applied and Environmental Microbiology.

[40]  Pieter C. Dorrestein,et al.  Translating metabolic exchange with imaging mass spectrometry , 2009, Nature chemical biology.

[41]  I. Paterson,et al.  Development of practical syntheses of the marine anticancer agents discodermolide and dictyostatin. , 2008, Natural product reports.

[42]  S. Salzberg,et al.  Optimized multiplex PCR: efficiently closing a whole-genome shotgun sequencing project. , 1999, Genomics.

[43]  J. Piel,et al.  Bacterial symbionts: prospects for the sustainable production of invertebrate-derived pharmaceuticals. , 2006, Current Medicinal Chemistry.

[44]  M. Platzer,et al.  Polyketide assembly lines of uncultivated sponge symbionts from structure-based gene targeting. , 2009, Nature chemical biology.

[45]  J. Fujimoto,et al.  Bacterial production of the tunicate-derived antitumor cyclic depsipeptide didemnin B. , 2011, Journal of natural products.

[46]  E. Raymond,et al.  Aplidine: a paradigm of how to handle the activity and toxicity of a novel marine anticancer poison. , 2007, Current pharmaceutical design.

[47]  D. Sherman,et al.  Merging the potential of microbial genetics with biological and chemical diversity: an even brighter future for marine natural product drug discovery. , 2004, Natural product reports.

[48]  Kai Blin,et al.  NRPSpredictor2—a web server for predicting NRPS adenylation domain specificity , 2011, Nucleic Acids Res..

[49]  H. Bode,et al.  A natural prodrug activation mechanism in nonribosomal peptide synthesis. , 2011, Nature chemical biology.